Skip to main content
GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · IEX Real-Time Price · USD
8.50
+0.44 (5.46%)
At close: Jul 19, 2024, 4:00 PM
8.51
+0.01 (0.12%)
Pre-market: Jul 22, 2024, 7:00 AM EDT

GoodRx Holdings Revenue

GoodRx Holdings had revenue of $764.16M in the twelve months ending March 31, 2024, with 2.27% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $197.88M with 7.55% year-over-year growth. In the year 2023, GoodRx Holdings had annual revenue of $750.27M.

Revenue (ttm)
$764.16M
Revenue Growth
+2.27%
P/S Ratio
4.17
Revenue / Employee
$1,101,094
Employees
694
Market Cap
3.19B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023750.27M-16.29M-2.12%
Dec 31, 2022766.55M21.13M2.83%
Dec 31, 2021745.42M194.72M35.36%
Dec 31, 2020550.70M162.48M41.85%
Dec 31, 2019388.22M138.70M55.59%
Dec 31, 2018249.52M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Oscar Health 6.54B
Amedisys 2.25B
HUTCHMED (China) 838.00M
Inari Medical 520.66M
iRhythm Technologies 513.17M
TG Therapeutics 289.33M
ADMA Biologics 283.18M
Twist Bioscience 277.49M
Revenue Rankings

GDRX News

More News